Boehringer Ingelheim Investigational Site — Newark, New Jersey

Boehringer Ingelheim Investigational Site is a clinical research site located in Newark, New Jersey, United States 07102.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Boehringer Ingelheim Investigational Site has participated in 2 clinical trials.

Therapeutic areas: HIV Infections.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in New Jersey · View every site in Newark

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boehringer Ingelheim Investigational Site?

Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boehringer Ingelheim Investigational Site conducted?

Boehringer Ingelheim Investigational Site has 2 clinical trials on record. Their work covers HIV Infections.

Is Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.